---
title: "BWC Genetic Laboratory Managed Equipment Service PME"
ocid: "ocds-h6vhtk-07b984"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07b984"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-07b984.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-07b984.json"
source: "Find A Tender Service"
current_stage: "Planning"
buyer: "Birmingham Women's and Children's NHS Foundation Trust"
published: "2026-11-11"
---

# BWC Genetic Laboratory Managed Equipment Service PME

Buyer: Birmingham Women's and Children's NHS Foundation Trust  
Current stage: Planning  
OCID: ocds-h6vhtk-07b984

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07b984)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-07b984.json)

## Summary

Birmingham Women’s and Children’s NHS Foundation Trust is reviewing how to manage equipment, consumables and related support for its Genetics Laboratory. The potential scope includes laboratory equipment procurement, servicing and maintenance, consumables purchasing, inventory and stock management, asset replacement and associated support services. The Trust is considering whether a managed equipment service could bring these functions together, while retaining clinical, scientific and regulatory oversight. The work relates to specialist medical services for genomic testing, delivered for the Genetics Laboratory in Birmingham. The review responds to growing complexity and scale in genomic technologies and a large, diverse equipment estate. University Hospitals Birmingham NHS Foundation Trust’s procurement team is managing the process on the Trust’s behalf.

This is at the planning stage: the buyer is conducting preliminary market engagement to help define the future requirements, scope, commercial structure and delivery model. No invitation to tender has been issued. The buyer expects to publish a subsequent notice on 1 February 2027. The engagement milestone is scheduled for 2 December 2026; this is a planning date, not a bid deadline. The current baseline expenditure across laboratory assets, consumables and support is around £12 million annually. The estimated procurement value is currently recorded as £0 because the future scope and commercial model remain undefined. One lot is planned, with an indicative contract period from 1 July 2027 to 30 June 2034. The procedure, award criteria and supplier eligibility requirements have not yet been settled in the planning information.

This review is relevant to suppliers able to provide an integrated managed equipment service for a specialist genetics laboratory, rather than only supplying individual items. Potentially well-placed businesses include providers combining laboratory equipment sourcing and lifecycle management with maintenance, consumables supply, inventory control and asset replacement planning. The buyer has identified a need to improve operational resilience, standardisation and long-term sustainability, manage a growing portfolio of service contracts, and reduce the burden of non-core operational work on laboratory staff. Suppliers should be prepared to explain how their model can support growth in genomic testing, continuity of laboratory operations and regulatory compliance while preserving the Trust’s clinical, scientific and regulatory oversight. The scale and diversity of the equipment estate and the range of linked services make this a substantial, multi-capability requirement.

## Notice

The Genetics Laboratory currently manages equipment procurement, maintenance arrangements, consumable purchasing, inventory management and asset replacement through a combination of scientific, technical, procurement and support staff. While this model has successfully supported significant growth in genomic testing activity, a number of opportunities have been identified to improve resilience, standardisation and long-term sustainability. Specific challenges identified include: * Increasing complexity and scale of genomic technologies. * Managing a growing portfolio of equipment service and maintenance contracts. * Requirement for more sophisticated inventory and stock management solutions. * Need for improved resilience and continuity arrangements. * Pressure on laboratory staff to undertake non-core operational activities. * Requirement to maintain regulatory compliance whilst supporting service growth. * Long-term capital replacement planning across a large and diverse equipment estate. BWC is therefore exploring whether a Managed Equipment Service model could provide operational, financial and strategic benefits whilst maintaining full clinical, scientific and regulatory oversight The contracting authority is undertaking a strategic review of its future operating models for laboratory assets, consumables, and associated support services. The current baseline expenditure across these categories is around PS12 million annually. The estimated procurement value is currently set at PS0 as the future scope, commercial structure, and delivery models are completely undefined. This UK2 notice is an invitation for preliminary market engagement to help shape our future requirements.

### Planning Information

The Genetics Laboratory currently manages equipment procurement, maintenance arrangements, consumable purchasing, inventory management and asset replacement through a combination of scientific, technical, procurement and support staff. While this model has successfully supported significant growth in genomic testing activity, a number of opportunities have been identified to improve resilience, standardisation and long-term sustainability. 
Specific challenges identified include:
• Increasing complexity and scale of genomic technologies.
• Managing a growing portfolio of equipment service and maintenance contracts.
• Requirement for more sophisticated inventory and stock management solutions.
• Need for improved resilience and continuity arrangements.
• Pressure on laboratory staff to undertake non-core operational activities.
• Requirement to maintain regulatory compliance whilst supporting service growth.
• Long-term capital replacement planning across a large and diverse equipment estate. 
BWC is therefore exploring whether a Managed Equipment Service model could provide operational, financial and strategic benefits whilst maintaining full clinical, scientific and regulatory oversight
The contracting authority is undertaking a strategic review of its future operating models for laboratory assets, consumables, and associated support services. The current baseline expenditure across these categories is around £12 million annually. The estimated procurement value is currently set at £0 as the future scope, commercial structure, and delivery models are completely undefined. This UK2 notice is an invitation for preliminary market engagement to help shape our future requirements.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/107076-2026 |
| Notice type | UK2 - Preliminary Market Engagement Notice |
| Procurement type | Standard |
| Procurement category | Services |
| Procurement method | Not Specified |
| Procurement method details | Not specified |
| Tender suitability | SME |
| Awardee scale | Not specified |
| All stages | Planning |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 11 Nov 2026 |
| Submission deadline | Not specified |
| Future notice date | 1 Feb 2027 |
| Award date | Not specified |
| Contract period | 1 Jul 2027 - 30 Jun 2034 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | Not specified |

## Status

| Field | Value |
| --- | --- |
| Tender status | Planning |
| Lots status | Planning |
| Awards status | Not specified |
| Contracts status | Not specified |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | Birmingham Women's and Children's NHS Foundation Trust |
| Locality | BIRMINGHAM |
| Postcode area | Birmingham |
| Postcode | B4 6NH |
| Country | England |
| ITL 1 | TLG West Midlands (England) |
| ITL 2 | TLG3 West Midlands |
| ITL 3 | TLG31 Birmingham |
| Local authority | Birmingham |
| Electoral ward | Ladywood |
| Westminster constituency | Birmingham Ladywood |
| Delivery location | TLG31 Birmingham |

## CPV Codes

### Divisions

- 85 - Health and social work services

### Codes

- 85121200 - Medical specialist services

## Release History

- 11 Nov 2026 at 12:24 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/107076-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/107076-2026
  11th November 2026 - Preliminary market engagement notice on Find a Tender

## Notice URLs

- https://www.bwc.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents
- https://www.uhb.nhs.uk/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-07b984. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-07b984.json.
